Details for Patent: 12,097,170

Which drugs does patent 12,097,170 protect, and when does it expire?

Patent 12,097,170 protects NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 12,097,170

Title:	Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation
Abstract:	A packaged, sealed container system for stable storage of a formulation of an oxygen-sensitive pharmaceutical compound, the packaged, sealed container system comprising a primary container including therein a formulation of an oxygen-sensitive pharmaceutical compound, a secondary outer container comprising a first flexible sheet layer, an opposing second flexible sheet layer, and a seal disposed along a common peripheral edge of the first and second flexible sheet layers, such that the primary container is disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. An oxygen scavenger is also disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. The oxygen scavenger is in fluid communication with the contents of the primary container.
Inventor(s):	Steven M. Cope, Allan E. Titus
Assignee:	Baxter Healthcare SA , Baxter International Inc
Application Number:	US17/249,642
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 12,097,170
Patent Claim Types: see list of patent claims	Use; Formulation; Delivery;

Drugs Protected by US Patent 12,097,170

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Baxter Hlthcare Corp	NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	214313-001	Jan 15, 2021	AP	RX	Yes	Yes	12,097,170		Y			TO RESTORE BLOOD PRESSURE IN ADULT PATIENTS WITH ACUTE HYPOTENSIVE STATES
Baxter Hlthcare Corp	NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	214313-002	Jan 15, 2021	AP	RX	Yes	Yes	12,097,170		Y			TO RESTORE BLOOD PRESSURE IN ADULT PATIENTS WITH ACUTE HYPOTENSIVE STATES
Baxter Hlthcare Corp	NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	214313-003	Nov 21, 2023	AP	RX	Yes	Yes	12,097,170		Y			TO RESTORE BLOOD PRESSURE IN ADULT PATIENTS WITH ACUTE HYPOTENSIVE STATES

International Family Members for US Patent 12,097,170

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	3174640
European Patent Office	4114336
World Intellectual Property Organization (WIPO)	2021178946